Home | Volume 12

Inhibition of focal adhesion kinase with her-2 targeted antibody pertuzumab (Omnitarg®, 2C4) in breast cancer cells

Dr. Emel Canbay et. al.

Download as PDF : 30._Canbay_et_al,_293-300.pdf : 476129 bytes


Previous Article: Recombinant adeno-associated virus as vaccine delivery vehicles
Next Article: Enhanced splenic protection and reduction of parasitaemia following transplantation of splenocytes overexpressing Bcl-2 in a murine malaria model
The Publication:
Inhibition of focal adhesion kinase with her-2 targeted antibody pertuzumab (Omnitarg®, 2C4) in breast cancer cells
is not formatted in HTML just yet, but will be available very soon!
Please view as a PDF: 30._Canbay_et_al,_293-300.pdf in the meantime.